Showing results (21-30 of 134) with videos related to
Sort By:
Pageof 14
Ginekologia Polska|June 21, 2016
Chemotherapy-induced peripheral neuropathy - epidemiology and pathogenesisDariusz Iżycki, Adam Niezgoda, Maciej Kaźmierczak, et al.Ginekologia Polska|April 6, 2019
The role of artificial nutrition in gynecological cancer therapyMagdalena Szewczuk, Emilia Gasiorowska, Konrad Matysiak, et al.Ginekologia Polska|May 7, 2019
Semaphorin 3A (SEMA3A), protocadherin 9 (PCdh9), and S100 calcium binding protein A3 (S100A3) as potential biomarkers of carcinogenesis and chemoresistance of different neoplasms, including ovarian cancer - review of literatureNatalia Izycka, Karolina Sterzynska, Radoslaw Januchowski, et al.Ginekologia Polska|February 12, 2015
[Bone loss in women with malignant genital neoplasms]Piotr Magnowski, Hubert Wolski, Magdalena Magnowska, et al.Fertility and Sterility|October 15, 2008
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancyEwa Nowak-Markwitz, Marcin Michalak, Mikołaj Olejnik, et al.Journal of Cancer Research and Clinical Oncology|June 27, 2014
Paraneoplastic neurological syndromes associated with ovarian tumorsMikolaj Piotr Zaborowski, Marek Spaczynski, Ewa Nowak-Markwitz, et al.Photodiagnosis and Photodynamic Therapy|February 22, 2011
Photodiagnosis and photodynamic therapy of endometriotic epithelial cells using 5-aminolevulinic acid and steroidsMaria Wołuń-Cholewa, Krzysztof Szymanowski, Ewa Nowak-Markwitz, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|August 13, 2002
Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in ratsMałgorzata Filip, Iwona Papla, Ewa Nowak, et al.Clinical Hemorheology and Microcirculation|June 26, 2002
Rheological and biochemical examination of red blood cells after treatment with different pharmacological and toxic substancesEwa Nowak, Grazyna Wyrwicz, Zbigniew Dabrowski, et al.Przeglad Menopauzalny = Menopause Review|March 3, 2017
PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targetingKarolina N Dziadkowiec, Emilia Gąsiorowska, Ewa Nowak-Markwitz, et al.Pageof 14